The apparent prevalence, the true prevalence

Biochem Med (Zagreb). 2022 Jun 15;32(2):020101. doi: 10.11613/BM.2022.020101.

Abstract

Serologic tests are important for conducting seroepidemiologic and prevalence studies. However, the tests used are typically imperfect and produce false-positive and false-negative results. This is why the seropositive rate (apparent prevalence) does not typically reflect the true prevalence of the disease or condition of interest. Herein, we discuss the way the true prevalence could be derived from the apparent prevalence and test sensitivity and specificity. A computer simulation based on the Monte-Carlo algorithm was also used to further examine a situation where the measured test sensitivity and specificity are also uncertain. We then complete our review with a real example. The apparent prevalence observed in many prevalence studies published in medical literature is a biased estimation and cannot be interpreted correctly unless we correct the value.

Keywords: diagnostic tests; prevalence; sensitivity; seroepidemiologic studies; specificity.

Publication types

  • Review

MeSH terms

  • Computer Simulation
  • Humans
  • Prevalence*
  • Sensitivity and Specificity
  • Seroepidemiologic Studies
  • Serologic Tests